Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6e960aa6ad2ba6401030159343ebe68 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2323-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L23-12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F6-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L23-0815 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L23-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L23-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-05 |
filingDate |
1996-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_817159a164dadf192181f94b1953db61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1226b6cbf83dbe87d74530ebcce4c661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_342131eb67b3bee321780d52e3903e51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c59f4a603e22a52a687f419f4b43057 |
publicationDate |
1998-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5811047-A |
titleOfInvention |
Polyolefin packaging material for drug packaging, method of production thereof and containers for drug packaging |
abstract |
The invention provides a polyolefin drug packaging material characterized in that the content, in the polyolefin, of substances containing 12 to 26 carbon atoms is not more than 150 ppm. The packaging material of the invention is useful because the risk of its reacting with and adversely affecting the drug packaged therewith is minimum. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101027031-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8029878-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008044606-A1 |
priorityDate |
1992-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |